Neodymium doped hydroxyapatite theranostic nanoplatforms for colon specific drug delivery applications
| dc.contributor.author | Victor, SP | |
| dc.contributor.author | Paul, W | |
| dc.contributor.author | Vineeth, VM | |
| dc.contributor.author | Komeri, R | |
| dc.contributor.author | Jayabalan, M | |
| dc.contributor.author | Sharma, CP | |
| dc.date.accessioned | 2017-03-10T03:27:44Z | |
| dc.date.available | 2017-03-10T03:27:44Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Theranostic nanoplatforms integrate therapeutic payloads with diagnostic agents, and help monitor therapeutic response. In this regard, stimuli responsive nanoplatforms further favour combinatorial therapeutic approach that can considerably improve efficacy and specificity of treatment. Herein, we present the engineering of a smart theranostic nanoplatform based on neodymium doped hydroxyapatite (HAN). The presence of neodymium endows the HAN nanoplatforms with near-infrared fluorescence capability. These HAN nanoparticles were then subsequently modified with alginic acid (HANA) to confer pH responsiveness to the synthesized nanoplatforms delivering them to the colon after oral administration. These nanoplatforms possessing optimum size, needle shaped morphology and negative zeta potential, are conducive to cellular internalization. On excitation at 410 nm they exhibit near infrared emission at 670 nm unraveling their theranostic capabilities. Cytotoxic effects systematically assessed using MIT and live dead assays reveal excellent viability. Raman microscopic imaging technique used to visualize uptake in HeLa cells demonstrate increased uptake from 4 to 16 h, with growing cluster size and localization in the cytoplasm. Moreover the concomitant presence of alginic acid manifested advantages of augmented loading and pH dependent release profiles of the model drug, 4 acetyl salicylic acid (4ASA). We could thus establish a theranostic system for early tumour detection, targeted tumour therapy and monitoring of colon cancer that can be administered via the oral route. (C) 2016 Elsevier B.V. All rights reserved. | |
| dc.identifier.citation | 145 ,;539-547 | en_US |
| dc.identifier.uri | 10.1016/j.colsurfb.2016.05.067 | |
| dc.identifier.uri | https://dspace.sctimst.ac.in/handle/123456789/10124 | |
| dc.publisher | COLLOIDS AND SURFACES B-BIOINTERFACES | |
| dc.subject | Biophysics; Chemistry; Materials Science | |
| dc.title | Neodymium doped hydroxyapatite theranostic nanoplatforms for colon specific drug delivery applications |